» Articles » PMID: 37510126

The Impact of Heart Rate Variability Monitoring on Preventing Severe Cardiovascular Events

Overview
Specialty Radiology
Date 2023 Jul 29
PMID 37510126
Authors
Affiliations
Soon will be listed here.
Abstract

The increase in the incidence of cardiovascular diseases worldwide raises concerns about the urgent need to increase definite measures for the self-determination of different parameters, especially those defining cardiac function. Heart rate variability (HRV) is a non-invasive method used to evaluate autonomic nervous system modulation on the cardiac sinus node, thus describing the oscillations between consecutive electrocardiogram R-R intervals. These fluctuations are undetectable except when using specialized devices, with ECG Holter monitoring considered the gold standard. HRV is considered an independent biomarker for measuring cardiovascular risk and for screening the occurrence of both acute and chronic heart diseases. Also, it can be an important predictive factor of frailty or neurocognitive disorders, like anxiety and depression. An increased HRV is correlated with rest, exercise, and good recovery, while a decreased HRV is an effect of stress or illness. Until now, ECG Holter monitoring has been considered the gold standard for determining HRV, but the recent decade has led to an accelerated development of technology using numerous devices that were created specifically for the pre-hospital self-monitoring of health statuses. The new generation of devices is based on the use of photoplethysmography, which involves the determination of blood changes at the level of blood vessels. These devices provide additional information about heart rate (HR), blood pressure (BP), peripheral oxygen saturation (SpO), step counting, physical activity, and sleep monitoring. The most common devices that have this technique are smartwatches (used on a large scale) and chest strap monitors. Therefore, the use of technology and the self-monitoring of heart rate and heart rate variability can be an important first step in screening cardiovascular pathology and reducing the pressure on medical services in a hospital. The use of telemedicine can be an alternative, especially among elderly patients who are associated with walking disorders, frailty, or neurocognitive disorders.

Citing Articles

Usefulness of Atherogenic Indices for Predicting High Values of Avoidable Lost Life Years Heart Age in 139,634 Spanish Workers.

Sastre-Alzamora T, Tarraga Lopez P, Lopez-Gonzalez A, Vallejos D, Paublini H, Ramirez Manent J Diagnostics (Basel). 2024; 14(21).

PMID: 39518356 PMC: 11545191. DOI: 10.3390/diagnostics14212388.


Validation and user experience of a dry electrode based Health Patch for heart rate and respiration rate monitoring.

Wei J, van den Broek T, van Baardewijk J, van Stokkum R, Kamstra R, Rikken L Sci Rep. 2024; 14(1):23098.

PMID: 39367187 PMC: 11452725. DOI: 10.1038/s41598-024-73557-8.


Technological Advances in the Diagnosis of Cardiovascular Disease: A Public Health Strategy.

Restrepo Tique M, Araque O, Sanchez-Echeverri L Int J Environ Res Public Health. 2024; 21(8).

PMID: 39200692 PMC: 11354672. DOI: 10.3390/ijerph21081083.


Analysis of the correlation between heart rate variability and palpitation symptoms in female patients with long COVID.

Jiang Y, Cheng Y, Xiao J, Wang Y, Chen G, Zhang Y Front Cardiovasc Med. 2023; 10:1273156.

PMID: 38045913 PMC: 10690811. DOI: 10.3389/fcvm.2023.1273156.


ECG-Free Heartbeat Detection in Seismocardiography and Gyrocardiography Signals Provides Acceptable Heart Rate Variability Indices in Healthy and Pathological Subjects.

Parlato S, Centracchio J, Esposito D, Bifulco P, Andreozzi E Sensors (Basel). 2023; 23(19).

PMID: 37836942 PMC: 10575135. DOI: 10.3390/s23198114.

References
1.
Yan S, Song X, Wei L, Gong Y, Hu H, Li Y . Performance of heart rate adjusted heart rate variability for risk stratification of sudden cardiac death. BMC Cardiovasc Disord. 2023; 23(1):144. PMC: 10032001. DOI: 10.1186/s12872-023-03184-0. View

2.
Pasadyn S, Soudan M, Gillinov M, Houghtaling P, Phelan D, Gillinov N . Accuracy of commercially available heart rate monitors in athletes: a prospective study. Cardiovasc Diagn Ther. 2019; 9(4):379-385. PMC: 6732081. DOI: 10.21037/cdt.2019.06.05. View

3.
Natarajan A, Pantelopoulos A, Emir-Farinas H, Natarajan P . Heart rate variability with photoplethysmography in 8 million individuals: a cross-sectional study. Lancet Digit Health. 2020; 2(12):e650-e657. DOI: 10.1016/S2589-7500(20)30246-6. View

4.
Hinde K, White G, Armstrong N . Wearable Devices Suitable for Monitoring Twenty Four Hour Heart Rate Variability in Military Populations. Sensors (Basel). 2021; 21(4). PMC: 7913967. DOI: 10.3390/s21041061. View

5.
Koenig C, Ammann R, Kuehni C, Roessler J, Brack E . Continuous recording of vital signs with a wearable device in pediatric patients undergoing chemotherapy for cancer-an operational feasibility study. Support Care Cancer. 2021; 29(9):5283-5292. PMC: 7925259. DOI: 10.1007/s00520-021-06099-8. View